Results 41 to 50 of about 257,633 (315)

Left ventricular assist device.

New England Journal of Medicine, 2002
To the Editor: The value of angiotensin-converting– enzyme (ACE) inhibitors, beta-blockers, and spironolactone has been well established by the results of numerous clinical trials. About 70 percent of the patients described by Rose et al. were treated with ACE inhibitors or angiotensin II–receptor antagonists; 35 to 40 percent received spironolactone ...
Jiménez-Navarro, Manuel, Molero, Encarnación, Teresa, Eduardo de   +2 more
openaire   +4 more sources

The influence of left ventricular assist device inflow cannula position on thrombosis risk

Artificial Organs, 2020
The use of left ventricular assist devices (LVADs) as a treatment method for heart failure patients has been steadily increasing; however, pathological studies showed presence of thrombi around the HeartWare ventricular assist device inflow cannula (IC ...
M. Ghodrati, Alexander Maurer, T. Schlöglhofer, Thananya Khienwad, D. Zimpfer, D. Beitzke, F. Zonta, F. Moscato, H. Schima, P. Aigner   +9 more
semanticscholar   +1 more source

Modalities of Left Ventricle Decompression during VA-ECMO Therapy

Membranes, 2021
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is used to sustain circulatory and respiratory support in patients with severe cardiogenic shock or refractory cardiac arrest.
Juan Pablo Ricarte Bratti, Yiorgos Alexandros Cavayas, Pierre Emmanuel Noly, Karim Serri, Yoan Lamarche   +4 more
doaj   +1 more source

Exploring the Influence of Parametrized Pulsatility on Left Ventricular Washout under LVAD Support: A Computational Study Using Reduced-Order Models [PDF]

arXiv, 2023
Medical therapy for patients with severe heart disease often relies on left ventricular assist devices (LVADs). It is an ongoing topic of research how complications like stagnation and thrombosis can be prevented by using artificial pulsatility. We study a parametric pulse profile and its effect on the left ventricular washout using a computational ...
arxiv  

Right and left ventricular assist devices are an option for bridge to heart transplantCentral MessagePerspective

JTCVS Open, 2022
Background: Patients with a left ventricular assist device with right ventricular failure are prioritized on the heart transplant waitlist; however, their post-transplant survival is less well characterized.
Yaron D. Barac, MD, PhD, Ronen Toledano, MD, Oliver K. Jawitz, MD, Jacob N. Schroder, MD, Mani A. Daneshmand, MD, Chetan B. Patel, MD, Dan Aravot, MD, Carmelo A. Milano, MD   +7 more
doaj  

Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundVasoplegia is associated with adverse outcomes following cardiac surgery; however, its impact following left ventricular assist device implantation is largely unexplored.
Kristen M. Tecson, Brian Lima, Andy Y. Lee, Fayez S. Raza, Grace Ching, Cheng‐Han Lee, Joost Felius, Ronald D. Baxter, Sasha Still, Justin D. G. Collier, Shelley A. Hall, Susan M. Joseph   +11 more
doaj   +1 more source

Semantic-aware Temporal Channel-wise Attention for Cardiac Function Assessment [PDF]

arXiv, 2023
Cardiac function assessment aims at predicting left ventricular ejection fraction (LVEF) given an echocardiogram video, which requests models to focus on the changes in the left ventricle during the cardiac cycle. How to assess cardiac function accurately and automatically from an echocardiogram video is a valuable topic in intelligent assisted ...
arxiv  

Non-intrusive PODI-ROM for patient-specific aortic blood flow in presence of a LVAD device [PDF]

, 2020
Left ventricular assist devices (LVADs) are used to provide haemodynamic support to patients with critical cardiac failure. Severe complications can occur because of the modifications of the blood flow in the aortic region. In this work, the effect of a continuous flow LVAD device on the aortic flow is investigated by means of a non-intrusive reduced ...
arxiv   +1 more source

In Full Flow: Left Ventricular Assist Device Infections in the Modern Era

Open Forum Infectious Diseases, 2020
With the rising prevalence of heart disease in the United States, there is increasing reliance on durable mechanical circulatory support (MCS) to treat patients with end-stage heart failure.
R. Zinoviev, C. Lippincott, S. Keller, N. Gilotra   +3 more
semanticscholar   +1 more source

Experience with left ventricular assist device usage in the treatment of end-stage heart failure [PDF]

Кардіохірургія та інтервенційна кардіологія, 2017
Heart failure potentially developing in most of heart diseases is a progressive process associated with high morbidity and mortality. Almost 3/4 of patients die within five years after first hospitalization because of heart failure.
B.M. Todurov, G.I. Kovtun, I.M. Kuzmich, M.V. Goncharenko, A.M. Druzhyna, A.O. Shpachuk, O.M. Postupalsky, S.O. Sheludko, S.M. Sudakevych, O.V. Stanyshevskyi, A.Yu. Melnyk   +10 more
doaj